13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
9:17 am Plenary Address: Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agens and adjuvants for vaccines. @ Acharya Hall
Plenary Address: Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agens and adjuvants for vaccines. @ Acharya Hall
Aug 13 @ 9:17 am – 9:55 am
Plenary Address: Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agens and adjuvants for vaccines. @ Acharya Hall | Vallikavu | Kerala | India
Suryaprakash Sambhara, DVM, Ph.D Chief, Immunology Section, Influenza Division, CDC, Atlanta, USA Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agents and adjuvants for vaccines. Currently used antiviral agents act by inhibiting viral entry,
11:11 am Invited Talk: Remote Patient Monitoring – Challenges and Opportunities @ Amriteshwari Hall
Invited Talk: Remote Patient Monitoring – Challenges and Opportunities @ Amriteshwari Hall
Aug 13 @ 11:11 am – 11:44 am
Invited Talk: Remote Patient Monitoring – Challenges and Opportunities @ Amriteshwari Hall | Vallikavu | Kerala | India
Jaydeep Unni, Ph.D. Sr. Project Manager, Robert Bosch Healthcare Systems, Palo Alto, CA Remote Patient Monitoring – Challenges and Opportunities Remote Patient Monitoring (RPM) is gaining importance and acceptance with rising number of chronic disease conditions and with increase in
11:25 am Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall
Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall
Aug 13 @ 11:25 am – 11:40 am
Invited Talk: “Inside-out” NF-kappa B signaling in cancer and other pathologies @ Acharya Hall | Vallikavu | Kerala | India
Shigeki Miyamoto, Ph.D. Professor, McArdle Laboratory for Cancer Research – UW Carbone Cancer Center Department of Oncology, School of Medicine and Public Health University of Wisconsin-Madison “Inside-out” NF-κB signaling in cancer and other pathologies The NF-κB/Rel family of transcription factors contributes to critical
2:40 pm Invited Talk: Applying Machine learning for Automated Identification of Patient Cohorts @ Sathyam Hall
Invited Talk: Applying Machine learning for Automated Identification of Patient Cohorts @ Sathyam Hall
Aug 13 @ 2:40 pm – 3:05 pm
Invited Talk: Applying Machine learning for Automated Identification of Patient Cohorts @ Sathyam Hall | Vallikavu | Kerala | India
Srisairam Achuthan, Ph.D. Senior Scientific Programmer, Research Informatics Division, Department of Information Sciences, City of Hope, CA, USA Applying Machine learning for Automated Identification of Patient Cohorts Srisairam Achuthan, Mike Chang, Ajay Shah, Joyce Niland Patient cohorts for a clinical
3:26 pm Invited Talk: Probing Estrogen Receptor – Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall
Invited Talk: Probing Estrogen Receptor – Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall
Aug 13 @ 3:26 pm – 3:57 pm
Invited Talk: Probing Estrogen Receptor - Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial @ Acharya Hall | Vallikavu | Kerala | India
Gokul Das, Ph.D. Co-Director, Breast Disease Site Research Group, Roswell Park Cancer Institute, Buffalo, NY Probing Estrogen Receptor−Tumor Suppressor p53 Interaction in Cancer: From Basic Research to Clinical Trial Tumor suppressor p53 and estrogen receptor have opposite roles in the
4:25 pm Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall
Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall
Aug 13 @ 4:25 pm – 5:04 pm
Invited Talk: Cancer Stem Cells – Target Colon Cancer @ Acharya Hall | Vallikavu | Kerala | India
Shrikant Anant, Ph.D. The Department of Molecular & Integrative Physiology, Kansas University Medical Center, USA Cancer Stem Cells: Target Colon Cancers Shrikant Anant, Deep Kwatra and Dharmalingam Subramaniam Colon cancer is a leading cause of cancer related deaths in the
5:06 pm Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall
Aug 13 @ 5:06 pm – 5:27 pm
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall | Vallikavu | Kerala | India
Bodo Eickhoff, Ph.D. Senior Vice-President, Head of Sales and Marketing for Roche Applied Science, Germany New paths for treatment of complex diseases: target combinatorial drug therapy Several types of diseases show a complex pathogenesis and require targeted as well as
6:26 pm Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall
Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall
Aug 13 @ 6:26 pm – 6:38 pm
Delegate Talk: A Non-toxic Approach to Prevent Secondary Effects of Chemotherapies @ Acharya Hall | Vallikavu | Kerala | India
Tanu Sharma, Narendra Parihar, Someshwar Nath, Azad Singh, Savneet Kaur, Simendra Singh and Chandi Mandal. In the recent years, there has been a surge in various forms of cancers especially in urban areas of India. Tumor recurrence and metastasis are